News

MIT and Recursion Launch Boltz-2, Open-Source AI Foundation Model for Structure and Binding Affinity Prediction

Researchers at MIT’s Jameel Clinic and CSAIL, in collaboration with Recursion and leveraging NVIDIA’s BioHive-2 supercomputer, have released Boltz-2, an …

Continue ›››

FutureHouse Debuts Scientific Reasoning LLM Model Trained for Chemistry

FutureHouse has released ether0, a 24B-parameter open-weight language model specialized for chemistry tasks. Built on Mistral 24B Instruct and refined …

Continue ›››

The Stage Is Set: London Biotechnology Show 2025

The inaugural London Biotechnology Show (LBS 2024) took place on 8–9 May 2024 at Olympia West, London, and culminated in …

Continue ›››

Kiin Bio Raises $2.2M Pre-Seed to Build AI Platform of "Virtual Scientists" for Drug Discovery

Kiin Bio, a 2024-founded startup developing an AI-native research platform for drug discovery, has raised $2.2 million in pre-seed funding …

Continue ›››

FDA Launches Internal AI Tool "Elsa" to Streamline Regulatory and Scientific Workflows

The U.S. Food and Drug Administration has deployed Elsa, an internal generative AI tool designed to assist employees with tasks …

Continue ›››

Sarepta Secures First FDA Platform Designation for Gene Therapy Delivery Technology

The U.S. FDA has granted Platform Technology Designation to Sarepta Therapeutics’ rAAVrh74 viral vector, the delivery component used in SRP-9003, …

Continue ›››

ImmunoPrecise AI Discovers Pan-Serotype Dengue Vaccine Target Fully In Silico

ImmunoPrecise Antibodies Ltd. (IPA) reported an in silico discovery of a single, strictly conserved epitope across all four dengue virus …

Continue ›››

Antheia Raises $56M Series C to Scale Biosynthetic Drug Ingredient Production, Expands to Asia

Menlo Park–based biomanufacturing company Antheia, founded in 2015 by Dr. Christina Smolke and Dr. Kristy Hawkins, announced a $56 million …

Continue ›››

AI-Designed Drug Reaches Clinical Validation: Insilico’s Rentosertib in Nature Medicine

Today, Nature Medicine published peer-reviewed Phase IIa clinical results for Rentosertib (ISM001-055), a TNIK inhibitor developed by Insilico Medicine using a …

Continue ›››

French Startup Using AI and Click Chemistry to Speed Up Microbial Detection Raises €5M

Diamidex, a Marseille-based company developing microbiological testing tools for industrial and environmental labs, has expanded the international reach of its …

Continue ›››

BioAge Preps Brain-Penetrant NLRP3 Inhibitor for Obesity IND

BioAge Labs has finished the pre-clinical package for BGE-102, an orally available, brain-penetrant NLRP3 inhibitor that the company is advancing …

Continue ›››

Insilico Medicine's AI Designs ENPP1 Inhibitor for Immune Modulation in Cancer

A study published in Nature Communications reports the development of ISM5939, an orally active small-molecule ENPP1 inhibitor designed using Insilico …

Continue ›››